97604-03-0 Usage
Explanation
The compound consists of 10 carbon atoms, 7 hydrogen atoms, 1 bromine atom, 2 nitrogen atoms, and 1 oxygen atom.
Explanation
It contains a pyrimidinone ring, which is a heterocyclic ring system consisting of both carbon and nitrogen atoms.
Explanation
The compound has a pyrimidinone ring as its core structure, which is a six-membered ring with alternating carbon and nitrogen atoms.
Explanation
A bromine atom is attached to a phenyl group, which is in turn attached to the pyrimidinone ring at the 3-position.
Explanation
2-(3-bromophenyl)-4(1H)-pyrimidinone can be used in the development of new drugs and pharmaceuticals due to its unique structure and properties.
Explanation
The compound can be used as a starting material or intermediate in organic synthesis to create other complex molecules.
Explanation
The compound may exhibit biological activity, making it a potential research tool in biochemical and pharmacological studies.
Type of compound
Heterocyclic compound
Structural feature
Pyrimidinone ring
Substituent
Bromophenyl group
Potential applications
Pharmaceutical industry
Use as a building block
Organic synthesis
Possible biological activity
Research tool
Check Digit Verification of cas no
The CAS Registry Mumber 97604-03-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,7,6,0 and 4 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 97604-03:
(7*9)+(6*7)+(5*6)+(4*0)+(3*4)+(2*0)+(1*3)=150
150 % 10 = 0
So 97604-03-0 is a valid CAS Registry Number.
97604-03-0Relevant academic research and scientific papers
Preparation of Triazolopyrimidines as Potential Antiasthma Agents
Medwid, Jeffrey B.,Paul, Rolf,Baker, Jannie S.,Brockman, John A.,Du, Mila T.,et al.
, p. 1230 - 1241 (2007/10/02)
With the use of the human basophil histamine release assay, 5-aryl-2-aminotriazolopyrimidines were found to be active as mediator release inhibitors.These compounds were prepared by reacting arylamidines with sodium ethyl formylacetate or with ethyl propiolate to give pyrimidinones.Treatment with phosphorus oxychloride gave a chloropyrimidine, which was converted to a hydrazinopyrimidine with hydrazine.Cyclization, using cyanogen bromide, gave the triazolopyrimidines, after a Dimroth rearrangement.Following a structure-activity evaluation, the5--2-amino (8-10), 5-(3-bromophenyl)-2-amino (8-13), 5--2-amino (8-11), and 5-(4-pyridinyl)-2-amino (6-7) compounds were found to have the best activity.They were chosen for further pharmacological and toxicological study.
